Cove Private Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.14M Buy
982
+57
+6% +$67.3K 0.2% 83
2026
Q2
$1.11M Buy
925
+154
+20% +$157K 0.21% 83
2026
Q1
$709K Buy
771
+304
+65% +$308K 0.16% 103
2025
Q4
$502K Buy
467
+168
+56% +$161K 0.15% 110
2025
Q3
$228K Buy
299
+10
+3% +$7.44K 0.07% 149
2025
Q2
$225K Buy
+289
New +$225K 0.08% 145

Other funds holding LLY

Cove Private Wealth's LLY Position: Q3 2026 in Review

Cove Private Wealth increased its Eli Lilly (LLY) stake by 6.2% in Q3 2026, buying an estimated $67.3K and bringing the position to 982 shares worth $1.14M. The position accounts for 0.2% of the portfolio, ranked #83.

Cove Private Wealth first reported a position in LLY in Q2 2025 and has held it in 6 quarters since. 4,601 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Cove Private Wealth held 982 shares of Eli Lilly worth $1.14M as of Q3 2026.
  • Cove Private Wealth bought 57 Eli Lilly shares in Q3 2026, an estimated $67.3K.
  • Eli Lilly made up 0.2% of Cove Private Wealth's portfolio in Q3 2026, its #83 holding.
  • Cove Private Wealth first reported a position in Eli Lilly in Q2 2025 and has held it in 6 quarters since.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Cove Private Wealth's 13F filing for Q3 2026, filed 28 Oct 2026.